STEPUP Clinical Trial
NCT05445375 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125
Last updated 2025-02-21
Summary
This study will test whether, among patients undergoing surgery for peripheral artery disease (PAD), the addition of an online multimedia patient education video to the current education regimen will improve PAD knowledge, activation, and self-care engagement. The study will randomize 150 participants to one of 2 groups: current education regimen vs. current education regiment with video. The primary outcome is stage of self-care engagement. Secondary outcomes are PAD knowledge, self-efficacy, and activation. A subset of participants will also be randomly selected to participate in semi-structured interviews. Study duration for participants is 6 months.
Conditions
Interventions
- OTHER
-
PAD education video
20-min online multi-media video
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-07
- Primary Completion
- 2024-03-07
- Completion
- 2024-03-07
Countries
- United States
Study Locations
More Related Trials
-
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
NCT01419418 ·Status: COMPLETED
-
Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
NCT00720577 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
NCT03358355 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
NCT03683628 ·Status: UNKNOWN ·Phase: NA
-
Unacylated Ghrelin to Improve Functioning in PAD
NCT04377126 ·Status: COMPLETED ·Phase: PHASE2
-
Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication
NCT03967730 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid
NCT02398266 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease
NCT02959047 ·Status: COMPLETED ·Phase: PHASE4
-
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
NCT03304821 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
NCT03297814 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System
NCT04585763 ·Status: COMPLETED ·Phase: NA
-
Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
NCT05166187 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
NCT06300450 ·Status: RECRUITING ·Phase: NA
-
Fisetin to Reduce Senescence and Mobility Impairment in PAD
NCT06399809 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease
NCT00443287 ·Status: COMPLETED ·Phase: PHASE2
-
Carnosine for Peripheral Arterial Disease
NCT04870229 ·Status: COMPLETED ·Phase: PHASE2
-
Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients
NCT05968118 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.
NCT00798005 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease
NCT03493412 ·Status: WITHDRAWN ·Phase: PHASE4
-
NAD Supplementation and Vascular Health in PAD
NCT06534944 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)
NCT02369848 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease
NCT00351286 ·Status: UNKNOWN ·Phase: PHASE2
-
Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease
NCT03247972 ·Status: TERMINATED
-
Cilostazol After Lower Extremity Arterial Revascularization Trial
NCT02374957 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)
NCT00390767 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2